FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and concerns a peptide H-Trp-Arg-Glu-(D-Arg)9-OH, possessing a dipeptidyl peptidase-4 inhibition property. Group of inventions also concerns an agent for treating diabetes mellitus type II, containing the said peptide as an active substance.
EFFECT: group of inventions provides wider spectrum of biologically active substances used for treating hyperglycemia, by creating a compound possessing a dipeptidyl peptidase-4 inhibition property.
4 cl, 3 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT OF PEPTIDE STRUCTURE, INHIBITING DIPEPTIDYL PEPTIDASE-4, AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2015 |
|
RU2589258C1 |
| PEPTIDE FOR MEDICAL TREATMENT OF PANCREATIC DIABETES OF 2ND TYPE AND ITS COMPLICATIONS | 2014 |
|
RU2573933C1 |
| ANALGESIC AGENT OF PEPTIDE STRUCTURE OF UNDERCAPEPTIDE CONTAINING D-OCTAARGININE VECTOR | 2013 |
|
RU2541127C1 |
| ANALGESIC AGENT OF PEPTIDE STRUCTURE BASED ON TRIDECAPEPTIDE CONTAINING D-OCTAARGININE VECTOR | 2013 |
|
RU2538727C1 |
| METHOD FOR PRODUCING PEPTIDE EXENATIDE | 2011 |
|
RU2458066C1 |
| HEMIN-PEPTIDES, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION AND USING AS ANTI-TUMOR AGENTS | 2004 |
|
RU2280649C1 |
| HEMIN-PEPTIDE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND USING AS ANTI-VIRAL AND VIRULICIDE AGENT | 2004 |
|
RU2296131C2 |
| GLP-1 ANALOGUE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND THEREOF APPLICATION | 2010 |
|
RU2565536C2 |
| METHOD OF SYNTHESIS OF PEPTIDEAMIDE DERIVATIVES OR THEIR PHYSIOLOGICALLY COMPATIBLE ACETATES OR HYDROCHLORIDES | 1991 |
|
RU2036200C1 |
| EXENATIDE ANALOGUE | 2020 |
|
RU2823623C1 |
